Biotech
-
BIO Supports Renegotiated U.S. Japan Trade Agreement
[ad_1] BIO helps the U.S. Trade Representative’s (USTR) negotiations with the Government of Japan as a possibility to develop U.S.…
Read More » -
Bellicum reports first data on ‘controllable’ CAR-T
[ad_1] Bellicum Pharma has the first data on BPX-601, its first CAR-T with a built-in activation change to spice up…
Read More » -
-390x220.jpg)
Sensorion’s vertigo drug hits tolerability endpoint in phase 2
[ad_1] A phase 2a trial of Sensorion’s vertigo seliforant has met its major tolerability endpoint. The trial discovered the histamine…
Read More » -
-390x220.jpg)
Axovant buys more gene therapies, setting it up for a busy 2019
[ad_1] Axovant has licensed two gene therapies from the University of Massachusetts Medical School (UMMS). The deal accelerates Axovant’s evolution…
Read More » -
Extendicare Announces December 2018 Dividend of C$0.04 per Share Toronto Stock Exchange:EXE
[ad_1] MARKHAM, Ontario, Dec. 13, 2018 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) introduced that it…
Read More » -
CRISPR controls obesity in mice by amplifying rather than editing genes
[ad_1] The genes SIM1 and MC4R regulate food consumption by signaling the sensation of being full, which is why mutations…
Read More » -
Sunovion, PsychoGenics nondopamine schizophrenia drug meets phase 2 endpoint
[ad_1] Sunovion Pharmaceuticals and PsychoGenics unveiled constructive phase 2 outcomes for a brand new schizophrenia therapy that doesn’t bind to…
Read More » -
Nobel Prize-Winning Chemists: Misguided GMO Fears Could Hinder Technology’s Societal Benefits
[ad_1] On Friday, December 7, two winners of the 2018 Nobel prize for Chemistry – American chemical engineer Frances Arnold…
Read More » -
Deep Blue Med Spa Announces New Profound Procedure to Treat Wrinkles and Rejuvenate Jawline
[ad_1] LONG ISLAND, NY, Dec. 13, 2018 (GLOBE NEWSWIRE) — Deep Blue Med Spa, overseen by the plastic surgeons at…
Read More » -
Amag merges with Perosphere, adding NOAC antidote
[ad_1] Amag Pharma has struck a merger deal with Perosphere, adding an anticoagulant reversal agent in midstage trials to its…
Read More »
